295 related articles for article (PubMed ID: 8635097)
41. [The place of radioimmunoscintigraphy in the diagnosis and follow-up of ovarian cancer in comparison with computed tomography and second-look surgery].
Barzen G; Friedmann W; Richter W; Schönegg W; Riess H; Eichstädt H; Lichtenegger W; Felix R
Nuklearmedizin; 1992 Feb; 31(1):16-23. PubMed ID: 1561116
[TBL] [Abstract][Full Text] [Related]
42. Monoclonal antibodies in ovarian and prostate cancer.
Neal CE; Swenson LC; Fanning J; Texter JH
Semin Nucl Med; 1993 Apr; 23(2):114-26. PubMed ID: 8511599
[TBL] [Abstract][Full Text] [Related]
43. Intense uptake of In-111 satumomab pendetide in an inflammatory mass.
Silberstein EB; Saeks E
Clin Nucl Med; 1996 Jan; 21(1):53-5. PubMed ID: 8741891
[TBL] [Abstract][Full Text] [Related]
44. Multicenter clinical trial of 111In-CYT-103 in patients with ovarian cancer.
Gallup DG
Targeted Diagn Ther; 1992; 6():111-24. PubMed ID: 1576342
[No Abstract] [Full Text] [Related]
45. Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT.
Stomper PC; D'Souza DJ; Bakshi SP; Rodriguez-Bigas M; Burke PA; Petrelli NJ
Radiology; 1995 Dec; 197(3):688-92. PubMed ID: 7480740
[TBL] [Abstract][Full Text] [Related]
46. Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer.
Topuz E; Aydiner A; Saip P; Eralp Y; Taş F; Salihoğlu Y; Tenekeci N
Eur J Gynaecol Oncol; 2000; 21(6):599-602. PubMed ID: 11214619
[TBL] [Abstract][Full Text] [Related]
47. Preoperative scintigraphy and operative probe scintimetry of colorectal carcinoma using technetium-99m-88BV59.
Moffat FL; Vargas-Cuba RD; Serafini AN; Jabir AM; Sfakianakis GN; Sittler SY; Robinson DS; Crichton VZ; Subramanian R; Murray JH
J Nucl Med; 1995 May; 36(5):738-45. PubMed ID: 7738642
[TBL] [Abstract][Full Text] [Related]
48. Use of radioimmunoscintigraphy with indium-111-labeled CYT-356 (ProstaScint) scan for evaluation of patients for salvage brachytherapy.
Fang DX; Stock RG; Stone NN; Krynyckyi BR; Kim CK; Machac J
Tech Urol; 2000 Jun; 6(2):146-50. PubMed ID: 10798816
[TBL] [Abstract][Full Text] [Related]
49. Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.
Raderer M; Becherer A; Kurtaran A; Angelberger P; Li S; Leimer M; Weinlaender G; Kornek G; Kletter K; Scheithauer W; Virgolini I
J Nucl Med; 1996 Sep; 37(9):1480-7. PubMed ID: 8790198
[TBL] [Abstract][Full Text] [Related]
50. Second-look laparotomy in epithelial ovarian carcinoma: precise definition, sensitivity, and specificity of the operative procedure.
Ballon SC; Portnuff JC; Sikic BI; Turbow MM; Teng NN; Soriero OM
Gynecol Oncol; 1984 Feb; 17(2):154-60. PubMed ID: 6706223
[TBL] [Abstract][Full Text] [Related]
51. Radioimmunoguided surgery of colorectal carcinoma with an 111In-labelled anti-TAG72 monoclonal antibody.
Muxi A; Pons F; Vidal-Sicart S; Setoain FJ; Herranz R; Novell F; Fernandez RM; Trias M; Setoain J
Nucl Med Commun; 1999 Feb; 20(2):123-30. PubMed ID: 10088160
[TBL] [Abstract][Full Text] [Related]
52. Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study.
Massari R; Barone M; Basilico R; Carella C; Colasante A; De Tursi M; Filippone A; Guetti L; Mani A
Minerva Chir; 2014 Feb; 69(1):17-26. PubMed ID: 24675243
[TBL] [Abstract][Full Text] [Related]
53. Computed tomography as a predictor of the extent of the disease and surgical outcomes in ovarian cancer.
Cerci ZC; Sakarya DK; Yetimalar MH; Bezircioglu I; Kasap B; Baser E; Yucel K
Ginekol Pol; 2016; 87(5):326-32. PubMed ID: 27304646
[TBL] [Abstract][Full Text] [Related]
54. [Value of computed tomography in the staging and predicting resectability of primary advanced ovarian carcinoma].
Lou FL; Shi YF
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):701-5. PubMed ID: 17274380
[TBL] [Abstract][Full Text] [Related]
55. [Predicting clinical chemo-sensitivity of primary ovarian cancer using adenosine triphosphate-tumor chemosensitivity assay combined with detection of drug resistance genes].
Zhao D; Zhang W; Li XG; Wang XB; Zhang LF; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):193-8. PubMed ID: 21575453
[TBL] [Abstract][Full Text] [Related]
56. [Experience in first-line chemotherapy with paclitaxel for the treatment of ovarian carcinomas].
Pete I; Szánthó A; Mayer A; Thurzó L; Pulay T
Orv Hetil; 2003 May; 144(19):919-24. PubMed ID: 12809068
[TBL] [Abstract][Full Text] [Related]
57. Correlation of abdominal computed tomography scanning and second-look operation findings in ovarian cancer patients.
Pectasides D; Kayianni H; Facou A; Bobotas N; Barbounis V; Zis J; Athanassiou A
Am J Clin Oncol; 1991 Dec; 14(6):457-62. PubMed ID: 1957833
[TBL] [Abstract][Full Text] [Related]
58. Preoperative diagnosis of ovarian carcinoma with a novel monoclonal antibody.
Lieberman G; Buscombe JR; Hilson AJ; Reid WM; Thakrar D; Maclean AB
Am J Obstet Gynecol; 2000 Sep; 183(3):534-40. PubMed ID: 10992170
[TBL] [Abstract][Full Text] [Related]
59. [Predictive value of abdominopelvic scan for optimal surgery of ovarian carcinoma].
Taïeb S; Leblanc E; Bonodeau F; Vennin P; Fournier C; Besson P
J Gynecol Obstet Biol Reprod (Paris); 2000 Oct; 29(6):555-63. PubMed ID: 11084462
[TBL] [Abstract][Full Text] [Related]
60. Pitfalls in interpretation of computed tomography prior to second-look laparotomy in patients with ovarian cancer.
Calkins AR; Stehman FB; Wass JL; Smirz LR; Ellis JH
Br J Radiol; 1987 Oct; 60(718):975-9. PubMed ID: 3676656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
